Jiang Qian - 31 Dec 2021 Form 4 Insider Report for LianBio (LIANY)

Role: China General Manager
Signature: By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol: LIANY
Transactions as of: 31 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Jan 2022, 15:15:29 UTC
Previous filing: 01 Nov 2021
Next filing: 05 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIAN	Ordinary Shares	Award	$0	+69,588		$0.000000	69,588	31 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on December 31, 2022; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on December 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Content

Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on December 31, 2022; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on December 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.